rs148891849
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001369.3(DNAH5):c.5281C>T(p.Arg1761*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000065 in 984,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R1761R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001369.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.5281C>T | p.Arg1761* | stop_gained | Exon 33 of 79 | 1 | NM_001369.3 | ENSP00000265104.4 | ||
| DNAH5 | ENST00000681290.1 | c.5236C>T | p.Arg1746* | stop_gained | Exon 33 of 79 | ENSP00000505288.1 |
Frequencies
GnomAD3 genomes AF: 0.0000184 AC: 2AN: 108870Hom.: 0 Cov.: 25 show subpopulations
GnomAD2 exomes AF: 0.0000216 AC: 5AN: 231214 AF XY: 0.0000159 show subpopulations
GnomAD4 exome AF: 0.0000650 AC: 64AN: 984892Hom.: 0 Cov.: 26 AF XY: 0.0000616 AC XY: 31AN XY: 502840 show subpopulations
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000184 AC: 2AN: 108870Hom.: 0 Cov.: 25 AF XY: 0.0000203 AC XY: 1AN XY: 49190 show subpopulations
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:3
- -
The p.R1761* pathogenic mutation (also known as c.5281C>T), located in coding exon 33 of the DNAH5 gene, results from a C to T substitution at nucleotide position 5281. This changes the amino acid from an arginine to a stop codon within coding exon 33. This variant has been identified in the homozygous state and/or in conjunction with other DNAH5 variant(s) in individual(s) with features consistent with primary ciliary dyskinesia (Hornef N et al. Am J Respir Crit Care Med, 2006 Jul;174:120-6; Failly M et al. J Med Genet, 2009 Apr;46:281-6; Hagen EM et al. Hum Genet, 2016 Dec;135:1355-1364). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
This sequence change creates a premature translational stop signal (p.Arg1761*) in the DNAH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH5 are known to be pathogenic (PMID: 11788826, 16627867). This variant is present in population databases (rs148891849, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 16627867, 19357118). ClinVar contains an entry for this variant (Variation ID: 220475). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Primary ciliary dyskinesia 3 Pathogenic:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at